This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 120/14/1415    most recent CIRCULATIONAHA.109.875583v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Zouggari, Y. Articles by Silvestre, J.-S. PubMed PubMed Citation Articles by Zouggari, Y. Articles by Silvestre, J.-S. Pubmed/NCBI databases Substance via MeSH Related Collections Angiogenesis Related Article

(Circulation. 2009;120:1415-1425.)
© 2009 American Heart Association, Inc.

Molecular Cardiology

Regulatory T Cells Modulate Postischemic Neovascularization

Yasmine Zouggari, MSc; Hafid Ait-Oufella, MD, PhD; Ludovic Waeckel, PhD; José Vilar, PhD; Céline Loinard, MSc; Clément Cochain, MSc; Alice Récalde, MSc; Micheline Duriez, BS; Bernard I. Levy, MD, PhD; Ester Lutgens, MD, PhD; Ziad Mallat, MD, PhD; Jean-Sébastien Silvestre, PhD

From Paris-Cardiovascular Research Center (Y.Z., L.W., J.V., C.L., C.C., A.R., M.D., B.I.L., Z.M., J.-S.S.), INSERM U970, Hôpital Européen Georges Pompidou, Université Paris 5, Paris, France; Service de Réanimation médicale (H.A.-O.), Hôpital Saint-Antoine, Paris, France; and Experimental Vascular Pathology (E.L.), Department of Pathology, Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, Netherlands.

Correspondence to Jean-Sebastien Silvestre, Paris-Cardiovascular Research Center, INSERM U970, Hôpital Européen Georges Pompidou, Université Paris 5, 56 rue Leblanc, 75015 Paris, France. E-mail Jean-Sebastien.Silvestre{at}inserm.fr

Received January 17, 2009; accepted July 27, 2009.

Background— CD4⁺ and CD8⁺ T lymphocytes are key regulators of postischemic neovascularization. T-cell activation is promoted by 2 major costimulatory signalings, the B7/CD28 and CD40–CD40 ligand pathways. Interestingly, CD28 interactions with the structurally related ligands B7-1 and B7-2 are also required for the generation and homeostasis of CD4⁺CD25⁺ regulatory T cells (Treg cells), which play a critical role in the suppression of immune responses and the control of T-cell homeostasis. We hypothesized that Treg cell activation may modulate the immunoinflammatory response to ischemic injury, leading to alteration of postischemic vessel growth.

Methods and Results— Ischemia was induced by right femoral artery ligation in CD28-, B7-1/2–, or CD40-deficient mice (n=10 per group). CD40 deficiency led to a significant reduction in the postischemic inflammatory response and vessel growth. In contrast, at day 21 after ischemia, angiographic score, foot perfusion, and capillary density were increased by 2.0-, 1.2-, and 1.8-fold, respectively, in CD28-deficient mice, which showed a profound reduction in the number of Treg cells compared with controls. Similarly, disruption of B7-1/2 signaling or anti-CD25 treatment and subsequent Treg deletion significantly enhanced postischemic neovascularization. These effects were associated with enhanced accumulation of CD3-positive T cells and Mac-3–positive macrophages in the ischemic leg. Conversely, treatment of CD28^–/– mice with the nonmitogenic anti-CD3 monoclonal antibody enhanced the number of endogenous Treg cells and led to a significant reduction of the postischemic inflammatory response and neovascularization. Finally, coadministration of Treg cells and CD28^–/– splenocytes in Rag1^–/– mice with hindlimb ischemia abrogated the CD28^–/– splenocyte-induced activation of the inflammatory response and neovascularization.

Conclusion— Treg cell response modulates postischemic neovascularization.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2009 120: 1337-1338. [Extract] [Full Text]